Vimarsana
Biggest News Aggregation in the World

Andrei Floroiu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Andrei Floroiu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Andrei Floroiu Today - Breaking & Trending Today

Rx Rundown: BridgeBio Pharma, Vertex Pharmaceuticals, Allakos and more - Vimarsana News

Rx Rundown: BridgeBio Pharma, Vertex Pharmaceuticals, Allakos and more

Check out this week’s medical marketing news, people on the move and industry chatter.

What's Going On With Vaxart Stock Today? - Vaxart (NASDAQ:VXRT) - Vimarsana News

What's Going On With Vaxart Stock Today? - Vaxart (NASDAQ:VXRT)

Vaxart shares are trading higher by around 8% Wednesday afternoon. The company recently secured a contract from the U.S. Government via the Department of Health and Human Services.

Vaxart CEO Resigns; Biotech Raises $10 Million in Stock Sale - Vimarsana News

Vaxart CEO Resigns; Biotech Raises $10 Million in Stock Sale

By Colin Kellaher Vaxart's top executive, Andrei Floroiu, has resigned as president, chief executive and a director of the clinical-stage biotechnology...

Vaxart, Inc. Announces Management Change - Vimarsana News

Vaxart, Inc. Announces Management Change

Chief Executive Officer Andrei Floroiu Resigns Chair Michael J. Finney, Ph.D. to Serve as Interim Chief Executive Officer SOUTH SAN FRANCISCO, Calif., Jan. 16, 2024 -- Vaxart, Inc. today...

Vaxart, Inc. (NASDAQ:VXRT) Q2 2023 Earnings Call Transcript - Vimarsana News

Vaxart, Inc. (NASDAQ:VXRT) Q2 2023 Earnings Call Transcript

Vaxart, Inc. (NASDAQ:VXRT) Q2 2023 Earnings Call Transcript August 3, 2023 Vaxart, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $0.19. Operator: Greetings, and welcome to the Vaxart Business Update and Second Quarter 2023 Financial Results Conference Call. A question-and-answer session will follow management’s opening remarks. Individual investors may submit written […]

Source: yahoo.com